Kandidat til bestyrelse
Selskabsmeddelelse 15/2025 22. april 2025 KANDIDAT TIL SELSKABETS BESTYRELSE: Som annonceret i selskabsmeddelelse 14/2025, så har nuværende bestyrelsesmedlem Jakob…
Transactions Made Under the Share Buy-back Programme for Stolt-Nielsen Limited
Reference is made to the stock exchange announcement from Stolt-Nielsen Limited (Oslo Børs: SNI) on April 3, 2025 regarding the continuation of its 2016 share buy-back programme of up to…
[ADVANCED MEDICAL SOLUTIONS GROUP PLC – 17 04 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Form 8.3 – [ALLIANCE PHARMA PLC – 17 04 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Elis: Disclosure of trading in own shares occured from April 15 to April 17, 2025
Disclosure of trading in own shares occurred from April 15 to April 17, 2025 Saint-Cloud, April 22, 2025 In accordance with the regulations on share buybacks, in particular Regulation (EU)…
Atlantic SuperConnection Spinout
Following the positive progress announced to the market on the Uprated Connection Agreement and the Cable Framework Agreement Global InterConnection Group Ltd (“GIG” or the “Company”) is delighted to announce…
Elis : Déclaration des transactions sur actions propres du 15 au 17 avril 2025
Déclaration des transactions sur actions propres réalisées du 15 au 17 avril 2025 Saint-Cloud, le 22 avril 2025 Conformément à la réglementation relative aux rachats d’actions, notamment le Règlement (UE)…
Chemung Financial Corporation Reports First Quarter 2025 Net Income of $6.0 million, or $1.26 per share
ELMIRA, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Chemung Financial Corporation (the “Corporation”) (Nasdaq: CHMG), the parent company of Chemung Canal Trust Company (the “Bank”), today reported net income of…
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application
TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL)…
James River to Hold Its First Quarter Earnings Conference Call on Tuesday, May 6, 2025
PEMBROKE, Bermuda, April 18, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. (NASDAQ: JRVR) will release first quarter 2025 earnings after the market closes on Monday, May 5, 2025.…